Headline News about Therapeuticsmd IncVia Benzinga
Exposures
Product Safety
TherapeuticsMD's Birth Control Med Receives FDA Response Letter To Revise Manufacturing Testing Limits
December 13, 2021
Via Benzinga
Exposures
Product Safety
TherapeuticsMD, Amneal Settle US Patent Litigation For Bijuva
December 08, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
TherapeuticsMD, Inc. (TXMD) Q3 2021 Earnings Call Transcript
November 12, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
If You Invested $1,000 In TherapeuticsMD Stock One Year Ago, Here's How Much You'd Have Now
September 17, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|